Provided by Tiger Trade Technology Pte. Ltd.

Ascendis Pharma A/S

251.95
-1.3400-0.53%
Post-market: 251.950.00000.00%19:30 EDT
Volume:329.92K
Turnover:82.87M
Market Cap:16.68B
PE:19.28
High:256.35
Open:256.35
Low:247.03
Close:253.29
52wk High:282.15
52wk Low:186.05
Shares:66.19M
Float Shares:65.54M
Volume Ratio:0.66
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):13.07
EPS(LYR):-4.4176
ROE:118.78%
ROA:9.58%
PB:9.95
PE(LYR):-57.03

Loading ...

Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND) and Concentra Group Holdings Parent, Inc. (CON)

TIPRANKS
·
Apr 16

Ascendis Pharma Share Conversion Reshapes Access And Liquidity On Nasdaq

Simply Wall St.
·
Apr 15

European Equities Traded in the US as ADRs Rise in Tuesday Trading

MT Newswires Live
·
Apr 14

How Investors May Respond To Ascendis Pharma (ASND) Achondroplasia Combo Data And YUVIWEL Launch

Simply Wall St.
·
Apr 11

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Apr 09

Ascendis Pharma Price Target Maintained With a $273.00/Share by Wedbush

Dow Jones
·
Apr 09

Wedbush Reaffirms Their Buy Rating on Ascendis Pharma (ASND)

TIPRANKS
·
Apr 09

Ascendis Pharma to list ordinary shares directly on Nasdaq from April 20

Reuters
·
Apr 09

Ascendis Pharma announces new data from COACH trial

TIPRANKS
·
Apr 08

Ascendis says COACH trial shows TransCon CNP plus hGH boosts arm span in achondroplasia

Reuters
·
Apr 08

European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading

MT Newswires Live
·
Apr 07

Ascendis Pharma Gets Orphan Drug Exclusivity for Yuviwel

Dow Jones
·
Apr 07

Ascendis Pharma gets orphan drug exclusivity for Yuviwel, launches in the U.S.

TIPRANKS
·
Apr 07

Analysts Are Bullish on Top Healthcare Stocks: Ascendis Pharma (ASND), Encompass Health (EHC)

TIPRANKS
·
Apr 06

Ascendis Pharma files Form 3 for director Jean-Jacques Bienaime

Reuters
·
Apr 02

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
Mar 31

How Investors May Respond To Ascendis Pharma (ASND) Growth‑Disorder Data And New Board Appointment

Simply Wall St.
·
Mar 31

Ascendis Pharma held annual general meeting with 90.16% of shares voted

Reuters
·
Mar 25

European Equities Traded in the US as American Depositary Receipts Climb in Monday Trading

MT Newswires Live
·
Mar 23

Ascendis Pharma A/S EVP and CFO Scott Thomas Smith files initial beneficial ownership statement

Reuters
·
Mar 19